Traws Pharma, Inc.

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

ON 01910.Na · Oncology
ON 01910.Na is a small molecule that targets the MDM2 protein.

Phase 2 pipeline

TRX-100

Phase 1 pipeline

irinotecan and ON 01910.Na
ON 01910.Na and irinotecan
ON 01910.Na and oxaliplatin
ON123300
oxaliplatin and ON 01910.Na

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Traws Pharma, Inc. portfolio CI brief
Traws Pharma, Inc. pipeline updates RSS

Frequently asked questions about Traws Pharma, Inc.

What is Traws Pharma, Inc.'s pipeline?

Traws Pharma, Inc. has 1 drugs in Phase 3, 1 in Phase 2, 5 in Phase 1. Late-stage candidates include ON 01910.Na.

Sector hub: All tracked pharma companies